All fda Articles
-
196News Briefs3 Million Bottles of Eye Drops Under Voluntary Recall
April 10, 2026 K.C. Pharmaceuticals is voluntarily recalling more than 3 million bottles of private-label eye drops due to “lack of assurance...
-
266News BriefsGlaukos Expands Portfolio With Commercial Launch of Epioxa
The first and only FDA-approved, incision-free, topical drug therapy for keratoconus March 19, 2026 Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and...
-
605News BriefsFDA Approves Tenpoint’s YUVEZZI, New Combo Drop for Presbyopia
Jan. 30, 2026 Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging...
-
370ResourcesMeet Essilor® Stellest® Lenses
Meet Essilor® Stellest® lenses, the first and only FDA market authorized spectacle lens to slow myopia progression in children*1. Click here to...
-
2.5KNews BriefsNew Virtual Reality & AI-Based Eye Testing Platform Registers with FDA
Next-generation technology for the eye exams you deliver.
-
4.2KNews BriefsOCT with AI Capabilities Given Clearance by FDA
An OCT with artificial intelligence capabilities may soon be available to ODs.
-
2.7KNews BriefsFirst Treatment to Directly Target Demodex Mites Gets FDA Approval
New treatment for demodex blephartis will soon be available.
